FluidAI Medical announced that it has raised CAD 15 million in the round of funding co- led by returning investors, SOSV Investments LLC and Graphene Ventures on October 10, 2023. The transaction included participation from returning investors, Boutique Venture Partners, Threshold Impact Ltd., new investors, IFG.VC Limited, Leva Capital, Juno Pharmaceuticals Pty Ltd, Kyto Technology and Life Science, Inc., a number of esteemed angels, funds and government funding organizations.
K2X Technology & Life Science, Inc.
Equities
KBPH
US5015722003
Financial & Commodity Market Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+4.33% | 76.85B | |
+6.64% | 46.25B | |
+0.51% | 37.37B | |
+4.33% | 34.97B | |
-24.81% | 11.92B | |
+10.68% | 9.72B | |
-29.62% | 7.81B | |
+13.82% | 7.4B | |
-5.49% | 7.34B |
- Stock Market
- Equities
- KBPH Stock
- News K2X Technology & Life Science, Inc.
- FluidAI Medical announced that it has received CAD 15 million in funding from a group of investors